Wannisa Khamaikawin

Lat Krabang, 10520, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

A temperature-sensitive and less immunogenic Sendai virus for efficient gene editing.

A temperature-sensitive and less immunogenic Sendai virus for efficient gene editing.

Journal: Journal of virology

Published: November 04, 2024

A temperature-sensitive and interferon-silent Sendai virus vector for CRISPR-Cas9 delivery and gene editing in primary human cells.

A temperature-sensitive and interferon-silent Sendai virus vector for CRISPR-Cas9 delivery and gene editing in primary human cells.

Journal: bioRxiv : the preprint server for biology

Published: May 15, 2024

CRISPR/Cas9 genome editing of CCR5 combined with C46 HIV-1 fusion inhibitor for cellular resistant to R5 and X4 tropic HIV-1.

CRISPR/Cas9 genome editing of CCR5 combined with C46 HIV-1 fusion inhibitor for cellular resistant to R5 and X4 tropic HIV-1.

Journal: Scientific reports

Published: October 20, 2023

In vivo selection of anti-HIV-1 gene-modified human hematopoietic stem/progenitor cells to enhance engraftment and HIV-1 inhibition.

In vivo selection of anti-HIV-1 gene-modified human hematopoietic stem/progenitor cells to enhance engraftment and HIV-1 inhibition.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: August 28, 2023

HIV-1 proviral DNA in purified peripheral blood CD34+ stem and progenitor cells in individuals with long-term HAART; paving the way to HIV gene therapy.

HIV-1 proviral DNA in purified peripheral blood CD34+ stem and progenitor cells in individuals with long-term HAART; paving the way to HIV gene therapy.

Journal: Heliyon

Published: August 04, 2023

Evaluation of a docetaxel-cisplatin-fluorouracil-Au complex in human oral carcinoma cell line.

Evaluation of a docetaxel-cisplatin-fluorouracil-Au complex in human oral carcinoma cell line.

Journal: Artificial cells, nanomedicine, and biotechnology

Published: March 23, 2023

Engineered Zinc Finger Protein Targeting 2LTR Inhibits HIV Integration in Hematopoietic Stem and Progenitor Cell-Derived Macrophages: In Vitro Study.

Engineered Zinc Finger Protein Targeting 2LTR Inhibits HIV Integration in Hematopoietic Stem and Progenitor Cell-Derived Macrophages: In Vitro Study.

Journal: International journal of molecular sciences

Published: January 12, 2022

Longitudinal clonal tracking in humanized mice reveals sustained polyclonal repopulation of gene-modified human-HSPC despite vector integration bias.

Longitudinal clonal tracking in humanized mice reveals sustained polyclonal repopulation of gene-modified human-HSPC despite vector integration bias.

Journal: Stem cell research & therapy

Published: July 21, 2021

The clonal repopulation of HSPC gene modified with anti-HIV-1 RNAi is not affected by preexisting HIV-1 infection.

The clonal repopulation of HSPC gene modified with anti-HIV-1 RNAi is not affected by preexisting HIV-1 infection.

Journal: Science advances

Published: July 29, 2019

Mechanisms of virus dissemination in bone marrow of HIV-1-infected humanized BLT mice.

Mechanisms of virus dissemination in bone marrow of HIV-1-infected humanized BLT mice.

Journal: eLife

Published: March 15, 2019

Modeling Anti-HIV-1 HSPC-Based Gene Therapy in Humanized Mice Previously Infected with HIV-1.

Modeling Anti-HIV-1 HSPC-Based Gene Therapy in Humanized Mice Previously Infected with HIV-1.

Journal: Molecular therapy. Methods & clinical development

Published: November 11, 2017

Combined Antiviral Therapy Using Designed Molecular Scaffolds Targeting Two Distinct Viral Functions, HIV-1 Genome Integration and Capsid Assembly.

Combined Antiviral Therapy Using Designed Molecular Scaffolds Targeting Two Distinct Viral Functions, HIV-1 Genome Integration and Capsid Assembly.

Journal: Molecular therapy. Nucleic acids

Published: April 07, 2015

Showing 1-12 of 14

Last Updated: 09/26/2026